June 08, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Patients who underwent corneal cross-linking for keratoconus had a temporary but statistically significant increase in IOP in the months after the procedure, according to a study published in Journal of Glaucoma. “The relationship between post-CXL biomechanical changes and tonometry in human eyes is not well understood, with studies reporting variable results in postoperative IOP measurements,”
June 08, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

An epithelium-off corneal cross-linking treatment has been approved in the U.S. for nearly a decade.During that time, we have…

Epioxa, an epithelium-on corneal collagen cross-linking therapy, made a significant and clinically meaningful difference in…

Epioxa obtained FDA approval in October 2025, which makes it the first and only FDA-approved epithelium-on, oxygen-enriched…

Recently I saw a patient with Down syndrome on whom I had performed bilateral corneal cross-linking 5 years ago. This young…

Find the latest Cornea and External Disease and Ophthalmology news articles, videos, podcasts, and meeting coverage from medical…

HELSINKI — As technology evolves, there is potential to quantify and automate presbyopia-correcting IOL selection through…